Fannie Mae, Freddie Mac shares tumble after conservatorship comments
Investing.com -- Oscar Health (NYSE:OSCR) stock fell 3.5% after the healthcare technology company revised its 2025 financial guidance following a review of second quarter Marketplace data that revealed higher-than-expected market risk scores.
The company now expects a loss from operations of approximately $230 million and a net loss of approximately $228 million for the second quarter ended June 30, 2025. This adjustment comes after analysis from Wakely, an independent actuarial firm, showed that ACA Marketplace risk scores have increased more than Oscar had previously estimated.
For the full year 2025, Oscar has revised its outlook, now anticipating total revenue of $12.0 billion to $12.2 billion, up from the previous analyst estimate of $11.3 billion. However, the company also raised its projected medical loss ratio to 86.0% to 87.0%, indicating higher expected medical costs relative to premium revenue.
"We are taking appropriate pricing actions for 2026 that reflect higher acuity in the individual market, and we will continue to take steps to deliver for our members, partners, and shareholders," said Mark Bertolini, CEO of Oscar Health. "Oscar has successfully navigated dynamic markets before and we remain committed to our long-term strategy."
While member utilization remained elevated in the second quarter, cost trends moderated compared to the first quarter of 2025. The company now expects a loss from operations between $300 million and $200 million for the full year.
Oscar plans to resubmit rate filings for 2026 in states covering approximately 98% of its current membership to account for the higher market risk scores in the ACA Marketplace.
The company will release its complete second quarter 2025 financial results on August 6, 2025.